Literature DB >> 19434224

Multiple resistant Pseudomonas aeruginosa in contemporary medical practice: findings from urinary isolates at a Nigerian University Teaching Hospital.

G T A Jombo1, P Jonah, J A Ayeni.   

Abstract

Pseudomonas aeruginosa is a bacterium that is often encountered in urinary tract infection (UTI) worldwide and has shown varied antibiotic susceptibility patterns. This study was therefore designed to ascertain the antibiotic susceptibility patterns of the organism in Jos. Data on antimicrobial susceptibility of P. aeruginosa generated from urine samples by the Microbiology laboratory of Jos University Teaching Hospital (JUTH) was compiled for a period of three years (July 2001-June 2004). Additional information was obtained from the records department of the hospital. Samples were collected, stored and processed using standard laboratory procedures. The rate of isolation of P. aeruginosa from urine samples was found to be 4.6% (n=127) from 12,458 samples. From male population 34% (n=43) were isolated and 66 % (n=84) were recovered from females population with a significant (P < 0.05) gender difference. All the 100 % isolates of P. aeruginosa were resistant to penicillin, cloxacillin, tetracycline, nitrofurantoin and nalidixic acid. while 67% were sensitive to augmentin, sensitivity to ofloxacin was 92%, ciprofloxacin 92% and cefuroxime (86%). The resistance pattern of P. aeruginosa from urine against antibiotics was extremely high. Prophylactic antibiotic medication against UTI should be carefully weighed against this undesirable possible outcome (resistance). Susceptibility testing should be adopted as a basic routine laboratory procedure in hospitals and clinics in order to guide appropriately on the right choice of antibiotics. Finally, ofloxacin, ciprofloxacin, and cefuroxime should be considered on isolation of P. aeruginosa from UTI, especially in the absence of a sensitivity report as well as for prophylactic options.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19434224     DOI: 10.4314/njps.v23i1-2.54944

Source DB:  PubMed          Journal:  Niger J Physiol Sci        ISSN: 0794-859X


  7 in total

1.  Pathogen burden & associated antibiogram of Pseudomonas spp. in a tertiary care hospital of India.

Authors:  Minu Kumari; Surbhi Khurana; Nidhi Bhardwaj; Rajesh Malhotra; Purva Mathur
Journal:  Indian J Med Res       Date:  2019-02       Impact factor: 2.375

2.  Prevalence of multiple antibiotics resistant (MAR) Pseudomonas species in the final effluents of three municipal wastewater treatment facilities in South Africa.

Authors:  Emmanuel E Odjadjare; Etinosa O Igbinosa; Raphael Mordi; Bright Igere; Clara L Igeleke; Anthony I Okoh
Journal:  Int J Environ Res Public Health       Date:  2012-06-01       Impact factor: 3.390

3.  Bacterial uropathogens isolates and antibiograms in children under 5 years of age.

Authors:  Mohamed Alkhatim Alsammani; Mohamed Issa Ahmed; Nahla Farouk Abdelatif
Journal:  Med Arch       Date:  2014-07-31

4.  Profile of Virulence Factors in the Multi-Drug Resistant Pseudomonas aeruginosa Strains of Human Urinary Tract Infections (UTI).

Authors:  Asghar Habibi; Ramin Honarmand
Journal:  Iran Red Crescent Med J       Date:  2015-12-22       Impact factor: 0.611

5.  Efficacy of Ethanolic Extract of Syzygium aromaticum in the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Clinical Isolates Associated with Urinary Tract Infections.

Authors:  Osama Ahmed; Hassan Mohamed; Wesam Salem; Magdy Afifi; Yuanda Song
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-15       Impact factor: 2.629

6.  Pseudomonas aeruginosa isolates and their antimicrobial susceptibility pattern among catheterized patients at Jimma University Teaching Hospital, Jimma, Ethiopia.

Authors:  Temesgen Bekele; Amene Tesfaye; Tsegaye Sewunet; Habtewold Deti Waktola
Journal:  BMC Res Notes       Date:  2015-09-28

7.  Prevalence and Susceptibility Pattern of Multi Drug Resistant Clinical Isolates of Pseudomonas aeruginosa in Karachi.

Authors:  Fouzia Khan; Adnan Khan; Shahana Urooj Kazmi
Journal:  Pak J Med Sci       Date:  2014-09       Impact factor: 1.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.